COH
Cochlear Ltd
$150.83
▼ -0.36%
Market cap
$9.87B
Turnover
$22,909,267
Last price
$150.83
Day change
-0.36%
Announcements
5
Range, past year
Open 272.9 · Low 88.74 · Now 150.8 · High 319.5
Open COH in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
COH momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
51/100
Wyckoff phase
Uptrend17d
Trend stage
Emerging
1 Day
-0.4%
1 Week
-0.8%
1 Month
+15.0%
1 Year
-45.0%
RSI
61
Avg daily range
2.9%
Cochlear Ltd scores 51 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Uptrend, where it has been for 17 trading days. The weekly timeframe reads Uptrend, which agrees with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads moderate.
What stands out
- Fresh trend age (20 days)
- MACD histogram positive & rising
- RSI in healthy zone (61)
Points to watch
Nothing flagged for COH on this reading.
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsCOH announcements
Recent price-sensitive releases.
- 2026-10-26 2026 AGM Chair and CEO & President Addresses Chair's Address - Other | Chair's Address to Shareholders
- 2026-08-18 FY26 Result - Presentation Company Presentation | Preliminary Final Report
- 2026-08-18 Appendix 4E Preliminary Final Report | Dividend Record Date | Dividend Pay Date | Dividend Rate
- 2026-08-18 FY26 Result - ASX & Media Release Preliminary Final Report | Dividend Rate
- 2026-04-22 Trading update and reduction to FY26 earnings guidance
More Health Care stocks
Most traded in the same sector.